Evidence map›Paper›PMID 37820110›Full record

ArticleBlood advances2024

Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.

Ofelia A Alvarez, Nora St Victor Dély, Michele Paul Hanna, Rony Saint Fleur, Marie Cetoute, Sarah Metalonis, Tally Hustace, Eric C Brown, Louis Herns Marcelin, Emanise Muscadin and 2 more

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. A Novel Newborn Screening Program for Sickle Cell Disease in Nigeria.International journal of neonatal screening · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ofelia A AlvarezDivision of Pediatric Hematology, University of Miami, Miami, FL.
Nora St Victor DélySaint Damien Hospital, Tabarre, Haiti.ORCID 0009-0005-7796-6246
Michele Paul HannaSacré Cœur Hospital, Milot, Haiti.
Rony Saint FleurJustinien University Hospital, Cap Haitien, Haiti.
Marie CetouteDivision of Pediatric Hematology, University of Miami, Miami, FL.
Sarah MetalonisDepartment of Public Health Sciences, University of Miami, Miami, FL.
Tally HustaceDivision of Pediatric Hematology, University of Miami, Miami, FL.
Eric C BrownDepartment of Public Health Sciences, University of Miami, Miami, FL.
Louis Herns MarcelinDepartment of Anthropology, University of Miami, Miami, FL.
Emanise MuscadinJustinien University Hospital, Cap Haitien, Haiti.
Ronald EveillardHospital of the University of State of Haiti, Port-au-Prince, Haiti.
Emmeline LereboursSaint Damien Hospital, Tabarre, Haiti.

Funding

Comparative Study of Haitian and Miami Cohorts of Haitian-American and Haitian Immigrant Children with Sickle Cell Disease (CSHSCD)R01HL149121 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALVAREZ, OFELIA AMPARO · 2019 to 2023
$2.7M
NHLBI NIH HHS R01 HL149121
6 · The paper itself

Abstract

abstractOne in 120 children are born with sickle cell disease (SCD) in Haiti. However, health care challenges include isolated newborn screening (NBS) activities and lack of transcranial Doppler (TCD) ultrasound to assess stroke risk. The implementation activities of the Comparative Study of Children in Haiti and Miami with Sickle Cell Disease involved both NBS and TCD ultrasound implementations at 4 Haitian clinical sites. We hypothesized that hospital-based newborn SCD screening and follow-up programs would be feasible at Haiti. A traditional NBS laboratory method with dried blood samples was performed at 3 Port-au-Prince sites, and the traditional method plus point-of-care (POC) testing was used at the 2 northern sites. The rate of clinical follow-up for newborns with SCD as the outcome for the NBS intervention was compared with that of the NBS method. The NBS programs identified SCD in 0.77% of 8224 newborns over a 24-month period. In the rural hospital assigned to the combination screening, 56% of newborns identified with POC testing returned for follow-up, compared with 0% when POC was not available (P = .044). Newborns who tested positive for SCD and children aged <6 years with SCD at the clinical sites were eligible for study follow-up. Accrual was successful: 165 participants (mean age, 42 months; 53% males; 93% hemoglobin SS) were recruited and received oral penicillin. TCD ultrasound screening was hampered by poor internet connections and trained staff leaving Haiti, with only 1 active site conducting screening. Despite challenges, the implementation of NBS and sickle cell programs in Haiti is feasible. We are in the process of understanding how to mitigate implementation limitations.

Indexed as

Anemia, Sickle CellNeonatal ScreeningChildChild, PreschoolFemaleFollow-Up StudiesHaitiHospitalsHumansInfant, NewbornMale

Identifiers

PMID37820110
PMCPMC10784669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.